International Conference on Cytopathology

Transforming the Future of Cytopathology
Event Dates
2015-08-24 - 2015-08-26
Attendees
300
Event contact title
International Conference on Cytopathology
Event contact first name
Robert
Event contact last name
Johnson
Event contact telephone number
16503539744
Description
Transforming the Diagnosis Process through Cytopathology OMICS International invites scholars, researchers, academicians, students and corporate entities across the globe to join at theInternational Conference on Cytopathology to have a meaningful discussion with scholars during August 24-26, 2015 in Toronto, Canada. The conference focuses on “Transforming the Future of Cytopathology”. Cytopathology-2015 offers several exciting topics for discussion including Cancer cytopathology, Cytopathology in Laboratory Medicine technology,Plant cytopathologyMolecular cytopathology, Cell Biology, Drug discovery in cytopathology and Cytopathology,Advanced Cytopathology, Veterinary cytopathology, and Infection Control Cytopathology. Toronto in Canada is hosting this conference as the Diagnosis sector has been expanding with tremendous speed in Toronto outperforming growth rates of the previous years. Toronto's Discovery District is a center for research in biomedicine. The Canadian pharmaceutical market ranked world's eighth largest in 2011, representing about 2.6 % of global pharmaceutical sales. The Canadian prescription of pharmaceutical market was worth an estimated $29 billion in 2013. Also by 2013, generic drugs accounted for just over 66 per cent of the 574 million prescriptions filled in Canada, but represented slightly less than 24 per cent of medication spending, as they are typically less expensive than brand-name drugs. The largest company in Canada is American-owned Johnson & Johnson with 2011 sales of $1.75 billion. The only Canadian-owned company among the largest 10 pharmaceutical corporations in Canada is Apotex, ranking fifth with 2011 sales of $1.21 billion. Several Canadian associations like Canadian Society of Cytopathology, Canadian Society of cytology, Canadian Society of Plant Biologists,Canadian Association of Pathologistsand Canadian Society for Pharmaceutical Sciences, Canadian Medical Association,and Canadian Society for Molecular Biosciences, Canadian association for Biotechnologist, Canadian Public Health Association, Canadian Society for Biochemistry, and Molecular and Cellular Biology have been focusing on Cytopathological research. Top universities in Canada including University of Toronto, McGill University, Queen's University, University of Ottawa, University of Alberta, University of Calgary, University of Manitoba, Dalhousie University, McMaster University, Western Universityand University of British Columbia have created conducive atmosphere for transforming the Cytopathological research. The organizing committee of Cytopathological-2015is gearing up to offer an exciting and informative conference program includingplenary lectures, symposia, workshops on a variety of topics, poster presentations and various programsfor participants from all over the world. Cytopathological-2015is a quintessential platform for presenting research on advancing science like Drug discovery, about marketing, exchanging ideasabout it and thus, contributes to the dissemination of knowledge for the benefit of both theacademia and business.Cytopathology is presence is inevitable at places where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. For more details please visit- http://cytopathology.conferenceseries.com/ Email:[email protected]
Partner Voices
MGM Resorts is committed to fostering an inclusive and diverse culture, not just among employees and guests but also within its supply chain. The company prioritizes procuring goods and services from businesses owned by minorities, women, veterans, people with disabilities, LGBTQ individuals and those facing economic disadvantages. This commitment is integral to MGM Resorts' global procurement strategy.    Through its voluntary supplier diversity program, MGM Resorts actively identifies and connects certified diverse-owned suppliers to opportunities within its supply chain. The company is on track to spend at least 15% of its biddable procurement with diverse-owned businesses by 2025, demonstrating that supplier diversity is not only a social responsibility but also a strategic business imperative.    Supplier diversity isn’t just the right thing to do – it’s good for business. A diverse supply chain allows access to a broader range of perspectives and experience, helping to drive innovation, entrepreneurship and resilience, while strengthening communities. At MGM Resorts, engaging diverse suppliers ensures best-in-class experiences for guests and clients. Supplier diversity ensures a more resilient supply chain while supporting economic development in the communities in which it operates.   The impact of MGM Resorts' supplier diversity initiatives is significant. In 2023, these efforts supported over 3,500 jobs across more than 30 states, contributed over $214 million in income for diverse-owned businesses and generated more than $62 million in tax revenue. The story extends beyond the numbers – it reflects the tangible benefits brought to small and diverse-owned businesses, fostering economic empowerment in their communities.    MGM Resorts also supports the development and business skills of diverse-owned businesses through investment, mentorship and education. Through the MGM Resorts Supplier Diversity Mentorship Program, the company identifies, mentors and develops diverse-owned businesses to fill its future pipeline, while providing businesses with tools and resources to empower and uplift. Since 2017, the program has successfully graduated 105 diverse-owned businesses and is on track to achieve its goal of 150 graduates by 2025.     MGM Resorts’ commitment to supplier diversity not only enhances its business operations but also plays a crucial role in uplifting communities and fostering economic development. This approach reinforces the idea that diversity is a powerful driver of innovation and resilience, benefiting both the company and the wider community.